RISPERDAL CONSTA
RISPERDAL CONSTA
Approved
DIN Number
02298465
Drug Class
Human
Market Date
Oct 24, 2007
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02298465
AIG Number0124332011
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX08 RISPERIDONE
Product Specifications
Dosage FormPowder For Suspension, Sustained-Release
,
Kit
Route of AdministrationIntramuscular
AHFS Classification28:16.08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
RISPERIDONEActive
Strength: 12.5 MG / VIAL
Monograph: RISPERIDONE